EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

Silvia Vázquez-Cuesta, Laura Villar, Nuria Lozano García, Ana I Fernández, María Olmedo, Luis Alcalá, Mercedes Marín, Patricia Muñoz, Emilio Bouza, Elena Reigadas

Frontiers in Cellular and Infection Microbiology · 12.04.2023 · 13

DOI: 10.3389/fcimb.2023.1130701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.04.2023. Verfasst von Silvia Vázquez-Cuesta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clostridioides difficile infection (CDI) is the main cause of nosocomial diarrhea in developed countries. A key challenge in CDI is the lack of objective methods to ensure more accurate diagnosis, especially when differentiating between true infection and colonization/diarrhea of other causes. The main objective of this study was to explore the role of the microbiome as a predictive biomarker of CDI.

Methods

Between 2018 and 2021, we prospectively included patients with CDI, recurrent CDI (R-CDI), non-CDI diarrhea (NO-CDI), colonization by C. difficile , and healthy individuals. Clinical data and fecal samples were collected. The microbiome was analyzed by sequencing the hypervariable V4 region of the 16S rRNA gene on an Illumina Miseq platform. The mothur bioinformatic pipeline was followed for pre-processing of raw data, and mothur and R were used for data analysis.

Results

During the study period, 753 samples from 657 patients were analyzed. Of these, 247 were from patients with CDI, 43 were from patients colonized with C. difficile , 63 were from healthy individuals, 324 were from NOCDI, and 76 were from R-CDI. We found significant differences across the groups in alpha and beta diversity and in taxonomic abundance. We identified various genera as the most significant biomarkers for CDI ( Bacteroides, Proteus, Paraprevotella, Robinsoniella ), R-CDI ( Veillonella, Fusobacterium, Lactobacillus, Clostridium sensu stricto I ), and colonization by C. difficile ( Parabacteroides, Faecalicoccus, Flavonifractor, Clostridium XVIII ).

Discussion

We observed differences in microbiome patterns between healthy individuals, colonized patients, CDI, R-CDI, and NOCDI diarrhea. We identified possible microbiome biomarkers that could prove useful in the diagnosis of true CDI infections. Further studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeClostridioides difficileClostridium InfectionsHumansRNA, Ribosomal, 16SFecesDiarrhea

Stichwörter der Autor:innen

16S rRNAC. difficileCDIR-CDImicrobiome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Biochemistry and Molecular Biology Department, Faculty of Biology, Universidad Complutense de Madrid (UCM), Madrid, Spain.
  • Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Respiratorias (CIBERES CB06/06/0058), Madrid, Spain.
  • Medicine Department, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland.

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Vázquez-Cuesta, S., Villar, L., García, N. L., Fernández, A. I., Olmedo, M., Alcalá, L., Marín, M., Muñoz, P., Bouza, E., & Reigadas, E. (2023). Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1130701

Vancouver

Vázquez-Cuesta S, Villar L, García NL, Fernández AI, Olmedo M, Alcalá L, et al. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1130701

BibTeX
@article{VzquezCuesta2023,
  author = {Vázquez-Cuesta, Silvia and Villar, Laura and García, Nuria Lozano and Fernández, Ana I and Olmedo, María and Alcalá, Luis and Marín, Mercedes and Muñoz, Patricia and Bouza, Emilio and Reigadas, Elena},
  title = {Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1130701}
}
Kostenlos starten →